References
Rowin J, Lewis SL (2005) Copper deficiency myeloneuropathy and pancytopenia secondary to overuse of zinc supplementation. J Neurol Neurosurg Psychiatry 76(5):750–1
Kumar N, Gross JB Jr, Ahlskog JE (2004) Copper deficiency myelopathy produces a clinical picture like subacute combined degeneration. Neurology 63(1):33–9
Gallieni M, Brancaccio D, Cozzolino M, Sabbioni E (1996) Trace elements in renal failure: are they clinically important? Nephrol Dial Transplant 11(7):1232–5
Bonomini M, Di Paolo B, De Risio F, Niri L, Klinkmann H, Ivanovich P, Albertazzi A (1993) Effects of zinc supplementation in chronic haemodialysis patients. Nephrol Dial Transplant 8(10):1166–8
Hedera P, Fink JK, Bockenstedt PL, Brewer GJ (2003) Myelopolyneuropathy and pancytopenia due to copper deficiency and high zinc levels of unknown origin: further support for existence of a new zinc overload syndrome. Arch Neurol 60(9):1303–6
Schleper B, Stuerenburg HJ (2001) Copper deficiency-associated myelopathy in a 46-year-old woman. J Neurol 248(8):705–6
Prodan CI, Holland NR, Wisdom PJ, Burstein SA, Bottomley SS (2002) CNS demyelination associated with copper deficiency and hyperzincemia. Neurology 59:1453–56
Author information
Authors and Affiliations
Corresponding author
Additional information
Received in revised form: 16 March 2006
Rights and permissions
About this article
Cite this article
Yaldizli, Ö., Johansson, U., Gizewski, E.R. et al. Copper deficiency myelopathy induced by repetitive parenteral zinc supplementation during chronic hemodialysis. J Neurol 253, 1507–1509 (2006). https://doi.org/10.1007/s00415-006-0259-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-006-0259-z